Alkem Laboratories Ltd. logo

Alkem Laboratories Ltd. (ALKEM)

Market Closed
15 Oct, 10:00 AM
XNSE XNSE
₹
5,120. 50
-80.5
-1.5478%
₹
655.74B Market Cap
- P/E Ratio
20% Div Yield
59,910 Volume
- Eps
₹ 5,201
Previous Close
Add Transaction
Day Range
5,120.5 5,249
Year Range
5,051 5,933.5
Want to track ALKEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALKEM closed today lower at ₹5,120.5, a decrease of -1.5478% from yesterday's close, completing a monthly decrease of -3.9216% or -₹209. Over the past 12 months, ALKEM stock lost -6.509%.
ALKEM pays dividends to its shareholders, with the most recent payment made on Sep 01, 2026. The next estimated payment will be in In 4 months on Mar 01, 2027 for a total of ₹10.
The last earnings report, released on May 29, 2026, missed the consensus estimates by -41.3%. On average, the company has fell short of earnings expectations by -31.9433%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).

ALKEM Chart

People also search for

Sun Pharmaceutical Industries Ltd.
₹ 1,764
+1.0078%
Tata Motors Ltd.
₹ 287.05
+1.1452%
Maruti Suzuki India Limited
₹ 11,445
+2.3886%
M&M
Mahindra & Mahindra Ltd.
₹ 2,861.7
+2.434%
Bajaj Auto Limited
₹ 10,385
+1.3171%

Alkem Laboratories Ltd. (ALKEM) FAQ

What is the stock price today?

The current price is ₹5,120.50.

On which exchange is it traded?

Alkem Laboratories Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is ALKEM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 20%.

What is its market cap?

As of today, the market cap is 655.74B.

Has Alkem Laboratories Ltd. ever had a stock split?

No, there has never been a stock split.

Alkem Laboratories Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. S. Venkatesh CEO
XNSE Exchange
Y0R6P5102 CUSIP
India Country
17,432 Employees
7 Aug 2026 Last Dividend
- Last Split
- IPO Date

Overview

Alkem Laboratories Limited stands as a notable entity in the pharmaceutical sector, with its core operations involving research and development, manufacturing, and the sale of pharmaceutical and nutraceutical products. The company, which finds its roots in India, has established a strong presence both locally and internationally, including in the United States. Since its inception in 1973, Alkem Laboratories has carved a niche in delivering high-quality healthcare products, underpinned by its headquarters located in Mumbai, India. It has successfully navigated the intricate landscape of the pharmaceutical industry to become a significant player known for its diversified range of products that address a spectrum of therapeutic areas.

Products and Services

Alkem Laboratories Limited offers a wide array of products and services spanning various therapeutic categories and healthcare needs:

  • Branded Generics and Generic Drugs: These formulations are crafted to cater to various health conditions, offering cost-effective alternatives without compromising on efficacy. They comprise a substantial part of Alkem's portfolio, aiming to make high-quality healthcare accessible to all.
  • Active Pharmaceutical Ingredients (APIs): As the backbone of drug manufacturing, APIs constitute the essential components that exert the intended effects in medications. Alkem Laboratories is engaged in the production of these crucial ingredients, contributing to the broader pharmaceutical manufacturing ecosystem.
  • Biosimilars: These are biologically derived medicines that are similar to another already approved biological medicine. They represent Alkem's foray into complex products that require sophisticated development capabilities, underscoring its commitment to innovation and advanced therapeutic options.
  • Nutraceuticals: Beyond traditional medications, the company also provides nutritional supplements and products designed to support overall health and well-being. These include vitamins, minerals, and nutrients that play a vital role in maintaining a balanced diet and healthy lifestyle.
  • Gastro-intestinal Products: Alkem Laboratories offers a range of products targeted at the treatment and management of gastrointestinal conditions, reflecting the company's dedication to addressing acute and chronic medical issues.
  • Pain/Analgesic, Anti-diabetic, Neuro/Central Nervous System (CNS), Gynecology, Respiratory, Dermatology, and Cardiac Products: The company has a diversified portfolio that covers a wide spectrum of therapeutic areas, providing effective solutions for pain management, diabetes care, neurological conditions, women's health, respiratory diseases, skin conditions, and cardiac health.
  • Over-the-Counter (OTC) Products: This range includes mouth wash, shampoos, pregnancy detection kits, and condoms, catering to everyday health and personal care needs. These products exemplify Alkem's versatility and its ability to meet varied consumer demands beyond prescription medication.

Contact Information

Address: Alkem House
Phone: 91 22 3982 9999